Mesenchymal stem cells (MSCs) are isolated from multiple biological tissues—adult bone
marrow and adipose tissues and neonatal tissues such as umbilical cord and placenta. In …

Adipose tissue is now on the top one of stem cell sources regarding its accessibility,
abundance, and less painful collection procedure when compared to other sources. The …

Stem cell-based therapies for neurodegenerative diseases aim at halting clinical
deterioration by regeneration and by providing local support for damaged tissue …

Mesenchymal stromal/stem cells (MSC) are promising candidates for cellular therapy of
different diseases in humans and in animals. Following the guidelines of the International …

Introduction We conducted a phase 1 clinical trial in nine patients with mild‐to‐moderate
Alzheimer's disease to evaluate the safety and dose‐limiting toxicity of stereotactic brain …

Stem cell therapy is an emerging alternative therapeutic or disease-modifying strategy for
amyotrophic lateral sclerosis (ALS). The aim of this open-label phase I clinical trial was to …

Recently, mesenchymal stromal cell (MSC)-based therapy has become an appreciated
therapeutic approach in the context of neurodegenerative disease therapy. Accordingly, a …

Multipotent mesenchymal stromal cells (MSCs) represent a promising cell-based therapy in
regenerative medicine and for the treatment of inflammatory/autoimmune diseases …

Objective To assess the safety and efficacy of 2 repeated intrathecal injections of autologous
bone marrow–derived mesenchymal stem cells (BM‐MSCs) in amyotrophic lateral sclerosis …

Current cell culture surfaces used for the expansion and production of mesenchymal stromal
cells (MSCs) are not optimized for the production of highly secretory and nonsenescent …